TABLE 1.

Demographic characteristics of subjects^a

Variable	Dose						Active subjects (n = 30)
	Placebo (n = 10)	100 mg (n = 6)	200 mg (n = 6)	400 mg (n = 6)	800 mg (n = 6)	1,200 mg (n = 6)
Gender, no. of subjects
Male (%)	10 (100)	6 (100)	6 (100)	6 (100)	6 (100)	5 (83)	29 (97)
Female (%)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	1 (17)	1 (3)
Race, no. of subjects
Caucasian (%)	1 (10)	0 (0)	1 (17)	0 (0)	0 (0)	3 (50)	4 (13)
Black (%)	3 (30)	2 (33)	4 (67)	2 (33)	1 (17)	2 (33)	10 (33)
Asian (%)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
Hispanic (%)	5 (50)	4 (67)	1 (17)	4 (67)	4 (67)	1 (17)	14 (47)
Other (%)	1 (10)	0 (0)	0 (0)	0 (0)	1 (17)	0 (0)	2 (7)
Age (yr)
Mean	27.8	32.3	31.8	25.2	27.8	25.2	28.5
SD	6.6	7.7	9.6	6.4	8.8	7.7	8.2
Range	19-37	25-42	23-45	19-33	21-41	18-38	18-45
wt (kg)
Mean	71.6	79.6	77.7	78.5	70.9	76.0	76.5
SD	8.4	5.9	6.9	12.6	9.0	5.7	8.4
Range	58-84	72-87	67-88	60-92	62-83	69-82	60-92

^an, Number of subjects.